Diagnostic imaging determined that in life, the young mamenchisaurid suffered from an osteogenic tumor, or a tumor that originates in bone-forming cells. This is the first report of an osteogenic ...

Tenosynovial giant cell tumor (TGCT) is a group of rare tumors. They are usually benign (not cancer) and tend to occur in people between 25 to 50 years old. The tumors affect areas of the joints ...

And when they tested it, it is called giant cell tumor of bone,” Kreil said. While these types of tumors are not cancerous, they can spread. “They had to amputate my foot and we did that to ...

Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.

Ms Garcia had a tenosynovial giant cell tumor (TGCT) - a rare type of tumor that grows in the joints and is not usually cancerous. Ms Garcia's was growing on both her finger bone and joint.

Emactuzumab demonstrated a 71% objective response rate, rapid tumor reduction, and manageable side effects in early trials. Emactuzumab has received fast track designation from the U.S. FDA for ...

Researchers said the size and placement of the tumor likely would have caused “severe discomfort” and mobility issues. Getty/iStock New evidence adds to a 2020 finding that dinosaurs had bone ...